An Exciting Update on VISION: the CURE OM Patient-Reported Registry
February 24, 2020This week, the MRF announced a transformational new partnership with Massachusetts General Hospital Cancer Center (MGHCC) to advance the development and launch of VISION, the first ever patient-powered and patient-reported ocular melanoma registry! Cen …
MD Anderson’s Hussein Tawbi, MD, PhD Named to President’s Council on Science and Technology
January 29, 2020January 29, 2020 – Yesterday, President Donald J. Trump announced his intent to appoint MD Anderson’s Hussein Tawbi, MD, PhD to the President’s Council of Advisors on Science and Technology (PCAST). As associate professor and deputy chairman of Melanom …
Leading Melanoma Organizations Applaud Congress for Supporting $20 Million for Defense-Funded Melanoma Research
December 19, 2019WASHINGTON, DC, December 19, 2019 – The Melanoma Research Alliance (MRA) and the Melanoma Research Foundation (MRF) applaud Congress for approving $20 million in funding for the Department of Defense (DoD)-funded Peer Reviewed Melanoma Research Program …
#EyeGetDilated: Shea B.
November 27, 2019Guest blog post by Shea Biurski, daughter of CURE OM Patient Steering Committee member and #EyeGetDilated advocate Sam Buirski: I still vividly remember the moment my mom walked through the doors of my camp classroom. I had been preparing my presentati …
Developing More Effective Treatments for Ocular Melanoma
November 22, 2019SKCC Research Discoveries Translate to More Effective Treatments for Ocular Melanoma Guest blog post by Andrew Aplin, PhD, Associate Director for Basic Science and the Program Leader for Cancer Cell Biology and Signaling (CCBS) in the NCI-designated Si …
Recent Comments